XENE
NASDAQ · Biotechnology
Xenon Pharmaceuticals Inc
$54.94
-0.23 (-0.42%)
Performance
1D
—
1W
—
1M
—
3M
+22.52%
6M
+44.66%
1Y
+57.42%
YTD
+23.49%
Open$55.56
Previous Close$55.17
Day High$55.96
Day Low$54.51
52W High$63.95
52W Low$26.74
Volume—
Avg Volume3.44M
Market Cap4.98B
P/E Ratio—
EPS$-4.36
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$42.54
Above
SMA 200
$37.78
Above
RSI (14)
57.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
27 analysts
Price Target
-63.6% upside
Current
$54.94
$54.94
Target
$19.98
$19.98
$12.55
$19.98 avg
$22.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.57M | 9.25M | 1.14B |
| Net Income | -395,268,289 | -383,962,720 | -213,860,892 |
| Profit Margin | -4,612.1% | -4,381.5% | -18.8% |
| EBITDA | -423,396,944 | -434,136,100 | -248,558,556 |
| Free Cash Flow | — | — | -268,893,932 |
| Rev Growth | -7.4% | -7.4% | +15.1% |
| Debt/Equity | — | — | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |